InvestSMART

Pro Medicus Limited (ASX: PME) - Announcements

Current share price for PME : $178.860 4.85 (2.64%)+

ASX company news and announcements for Pro Medicus Limited (PME) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Pro Medicus Limited (PME) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Pro Medicus Limited (PME), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Pro Medicus Limited (PME)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$18,685 Becoming a substantial holder - PPT 5 Jun 2015 4:43PM $2.170 $178.860 risen by 8,142.40%
$18,685 Ceasing to be a substantial holder from PPT 28 May 2015 4:48PM $2.280 $178.860 risen by 7,744.74%
$18,685 Change in substantial holding from PPT 27 May 2015 4:49PM $2.280 $178.860 risen by 7,744.74%
$18,685 PME receives FDA clearance for Visage Ease Pro 19 May 2015 10:03AM $2.080 $178.860 risen by 8,499.04%
$18,685 PME signs $9.5M deal with University of Florida 21 Apr 2015 10:02AM $1.510 $178.860 risen by 11,745.03%
$18,685 S&P DJ Indices Announces March Quarterly Review 6 Mar 2015 8:44AM n/a $178.860 n/a
$18,685 Appendix 4D 20 Feb 2015 11:10AM $1.550 $178.860 risen by 11,439.35%
$18,685 PME signs $5M deal with Zwanger-Pesiri 12 Jan 2015 10:03AM $1.215 $178.860 risen by 14,620.99%
$18,685 Open Briefing - North American market update 18 Dec 2014 2:09PM $1.120 $178.860 risen by 15,869.64%
$18,685 PME signs $8M deal with Wellspan Health 20 Nov 2014 10:27AM $1.080 $178.860 risen by 16,461.11%
$18,685 Open Briefing - CEO on FY14 Results 22 Aug 2014 12:04PM $0.925 $178.860 risen by 19,236.22%
$18,685 Appendix 4E - Preliminary Final Report 22 Aug 2014 10:08AM $0.875 $178.860 risen by 20,341.14%
$18,685 Open Briefing CEO on Major US Deal and North American update 28 Apr 2014 10:14AM $0.815 $178.860 risen by 21,846.01%
$18,685 PME signs large US health network 22 Apr 2014 10:12AM $0.840 $178.860 risen by 21,192.86%
$18,685 On market share buy-back 18 Mar 2014 9:26AM $0.760 $178.860 risen by 23,434.21%
$18,685 Open Briefing - CEO on HY14 results 21 Feb 2014 12:21PM $0.820 $178.860 risen by 21,712.20%
$18,685 Appendix 4D 21 Feb 2014 10:29AM $0.820 $178.860 risen by 21,712.20%
$18,685 Pro Medicus' Visage Technology Goes Live with vRad 21 Nov 2013 1:45PM $0.660 $178.860 risen by 27,000%
$18,685 Signs US$4M deal with large US Veterans Affairs Network 21 Oct 2013 11:42AM $0.480 $178.860 risen by 37,162.50%
$18,685 Appendix 4E - Preliminary Final Report 23 Aug 2013 10:22AM $0.480 $178.860 risen by 37,162.50%
$18,685 PME signs pivotal deal with v-Rad 8 May 2013 10:23AM $0.520 $178.860 risen by 34,296.15%
$18,685 On market share buy-back 27 Feb 2013 9:35AM $0.520 $178.860 risen by 34,296.15%
$18,685 Appendix 4D 22 Feb 2013 10:16AM $0.475 $178.860 risen by 37,554.74%
$18,685 Open Briefing - CEO on Annual General Meeting 20 Nov 2012 12:03PM $0.430 $178.860 risen by 41,495.35%
$18,685 PME launches new technology platform 30 Aug 2012 11:13AM $0.370 $178.860 risen by 48,240.54%

576 - 600 of 669 results

Page 24 of 27

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.